AIDS research team in US loses $1.38M grant (Update)

July 8, 2014 by David Pitt

An AIDS research team at Iowa State University will not get the final $1.38 million payment of a National Institutes of Health five-year grant after a team member admitted last year to faking research results, the NIH said Tuesday.

One of the members of the research team, Dong-Pyou Han, a native of South Korea, has pleaded not guilty in federal court to four counts of making false statements in research reports. He is free on bond awaiting trial scheduled for Sept. 2.

The research team, led by biomedical sciences professor Michael Cho, was awarded $6.8 million to be paid over five years by the NIH, but it won't see the last payment. The team previously received grants totaling $7.6 million.

The university has agreed to repay the government $496,000 for Han's salary and other costs tied to his employment at ISU during the research. Han may not apply for or receive grants from the U.S. government for three years, the NIH said, but Cho's team and other researchers at ISU can.

"NIH makes funding decisions based on scientific merit of the proposed research to eligible organizations/institutions. The researchers are eligible to apply for future NIH grant funding through their institutions just as other researchers may apply," the agency said in an emailed statement.

University spokesman John McCarroll said the team, which consists of 10 researchers, has sufficient funding to continue its work.

He said Cho continues to be a respected researcher and people seem to understand he was not aware of faked lab work. Cho did not immediately respond to messages for comment.

According to the indictment filed last month in U.S. District Court in Des Moines, Han's misconduct dates to when he worked at Case Western Reserve University in Cleveland under Cho, who was leading a team testing an experimental HIV vaccine on rabbits.

Starting in 2008, Cho's team received initial NIH funding. Cho reported soon that his vaccine was causing rabbits to develop antibodies to HIV, which was considered a major breakthrough in HIV/AIDS vaccine research by NIH officials and the research community.

Iowa State recruited Cho in 2009, and his team—including Han—soon received a five-year grant to continue the research. The team reported progress until a group of researchers at Harvard University found in January 2013 the promising results had been achieved with rabbit blood spiked with human antibodies.

An ISU investigation pinpointed Han leading him to write in a Sept. 30, 2013, confession letter that he started the fraud in 2009 "because he wanted (results) to look better" and that he acted alone.

"I was foolish, coward, and not frank," he wrote.

Explore further: Study of antibody evolution charts course toward HIV vaccine

Related Stories

Study of antibody evolution charts course toward HIV vaccine

March 2, 2014

In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe ...

Researcher charged in major HIV vaccine fraud case

June 24, 2014

Responding to a major case of research misconduct, federal prosecutors are taking a rare step by charging a scientist with fraud after he admitted falsifying data while researching an HIV vaccine.

Recommended for you

Videos reveal how HIV spreads in real time

October 2, 2015

How retroviruses like HIV spread in their hosts had been unknown—until a Yale team devised a way to watch it actually happen in a living organism. The elaborate and sometimes surprising steps the virus takes to reach and ...

Researchers find proteins that shut down HIV-1

September 30, 2015

A pair of studies by researchers at the University of Massachusetts Medical School, the University of Trento in Italy, and the University of Geneva in Switzerland, point to a promising new anti-retroviral strategy for combating ...

An antibody that can attack HIV in new ways

September 11, 2015

Proteins called broadly neutralizing antibodies (bNAbs) are a promising key to the prevention of infection by HIV, the virus that causes AIDS. bNAbs have been found in blood samples from some HIV patients whose immune systems ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.